Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Grayson

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|October 3, 2019
Resuscitative endovascular balloon occlusion of the aorta (REBOA) in a swine model of hemorrhagic shock and blunt thoracic injuryCarl A Beyer, Guillaume L Hoareau, Harris W Kashtan, et al.
British Journal of Pharmacology|August 9, 2006
In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?B B Yao, S Mukherjee, Y Fan, et al.
Science (New York, N.Y.)|July 26, 2014
Early Americans: respecting ancestorsD K Grayson, D J Meltzer, J E Buikstra, et al.
Journal of Medicinal Chemistry|November 20, 2009
Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activityJennifer M Frost, Michael J Dart, Karin R Tietje, et al.
Shock (Augusta, Ga.)|September 25, 2025
Metabolomic assessment of low versus high volume resuscitation in a combined porcine model of severe burn and traumatic brain injuryLinda M Schutzman, Sandra L Taylor, Oliver Fiehn, et al.
Science (New York, N.Y.)|July 21, 2007
Comment on "Redefining the age of Clovis: implications for the peopling of the Americas"Gary Haynes, David G Anderson, C Reid Ferring, et al.
Journal of Medicinal Chemistry|March 4, 2008
Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activityJennifer M Frost, Michael J Dart, Karin R Tietje, et al.
British Journal of Pharmacology|November 13, 2007
In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain modelsB B Yao, G C Hsieh, J M Frost, et al.
Bioorganic & Medicinal Chemistry Letters|February 29, 2012
Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain managementDerek W Nelson, Jennifer M Frost, Karin R Tietje, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2008
Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imagingBetty B Yao, Gin Hsieh, Anthony V Daza, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|October 3, 2019
Resuscitative endovascular balloon occlusion of the aorta (REBOA) in a swine model of hemorrhagic shock and blunt thoracic injuryCarl A Beyer, Guillaume L Hoareau, Harris W Kashtan, et al.
British Journal of Pharmacology|August 9, 2006
In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?B B Yao, S Mukherjee, Y Fan, et al.
Science (New York, N.Y.)|July 26, 2014
Early Americans: respecting ancestorsD K Grayson, D J Meltzer, J E Buikstra, et al.
Journal of Medicinal Chemistry|November 20, 2009
Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activityJennifer M Frost, Michael J Dart, Karin R Tietje, et al.
Shock (Augusta, Ga.)|September 25, 2025
Metabolomic assessment of low versus high volume resuscitation in a combined porcine model of severe burn and traumatic brain injuryLinda M Schutzman, Sandra L Taylor, Oliver Fiehn, et al.
Science (New York, N.Y.)|July 21, 2007
Comment on "Redefining the age of Clovis: implications for the peopling of the Americas"Gary Haynes, David G Anderson, C Reid Ferring, et al.
Journal of Medicinal Chemistry|March 4, 2008
Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activityJennifer M Frost, Michael J Dart, Karin R Tietje, et al.
British Journal of Pharmacology|November 13, 2007
In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain modelsB B Yao, G C Hsieh, J M Frost, et al.
Bioorganic & Medicinal Chemistry Letters|February 29, 2012
Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain managementDerek W Nelson, Jennifer M Frost, Karin R Tietje, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2008
Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imagingBetty B Yao, Gin Hsieh, Anthony V Daza, et al.
Pageof 6